Our Notice and Proxy Statement for Teva’s meeting of shareholders, which was filed with the US Securities and Exchange Commission on April 21, 2021, includes additional corporate governance disclosures. Ethics and Transparency in Clinical Trials We have an obligation to report our clinical trial results according to the highest ethical standards.